伟思医疗
(688580)
| 流通市值：35.98亿 | | | 总市值：35.98亿 |
| 流通股本：9577.13万 | | | 总股本：9577.13万 |
| 利润表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 营业总收入 | 324,932,138.88 | 226,437,246.19 | 106,040,321.83 | 462,725,664.61 |
| 营业总成本 | 237,185,927.38 | 158,213,887.06 | 74,643,980.57 | 344,480,453.6 |
| 其他经营收益 | | | | |
| 营业利润 | 140,948,572.23 | 114,669,412.01 | 70,365,222.49 | 152,323,627.38 |
| 利润总额 | 140,592,136.44 | 114,315,750.47 | 70,365,221.81 | 154,431,660.71 |
| 净利润 | 123,967,947.32 | 100,122,719.93 | 61,573,316.79 | 138,072,645.5 |
| 每股收益 | | | | |
| 其他综合收益 | - | - | - | - |
| 综合收益总额 | 123,967,947.32 | 100,122,719.93 | 61,573,316.79 | 138,072,645.5 |
| 资产负债表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 流动资产: | | | | |
| 流动资产合计 | 974,216,061.85 | 962,209,034.34 | 1,032,146,463.28 | 1,115,441,214.83 |
| 非流动资产: | | | | |
| 非流动资产合计 | 831,055,830.14 | 831,976,501.03 | 830,822,948.46 | 793,607,001.71 |
| 资产总计 | 1,805,271,891.99 | 1,794,185,535.37 | 1,862,969,411.74 | 1,909,048,216.54 |
| 流动负债: | | | | |
| 流动负债合计 | 91,402,026.61 | 102,537,629.23 | 106,918,821.22 | 215,416,393.2 |
| 非流动负债: | | | | |
| 非流动负债合计 | 415,833.45 | 528,170.8 | 574,036.51 | 585,697.72 |
| 负债合计 | 91,817,860.06 | 103,065,800.03 | 107,492,857.73 | 216,002,090.92 |
| 所有者权益(或股东权益): | | | | |
| 归属于母公司股东权益合计 | 1,713,454,031.93 | 1,691,119,735.34 | 1,755,476,554.01 | 1,693,046,125.62 |
| 股东权益合计 | 1,713,454,031.93 | 1,691,119,735.34 | 1,755,476,554.01 | 1,693,046,125.62 |
| 负债和股东权益合计 | 1,805,271,891.99 | 1,794,185,535.37 | 1,862,969,411.74 | 1,909,048,216.54 |
| 现金流量表 |
| 报告期 | 2026-09-30 | 2026-06-30 | 2026-03-31 | 2025-12-31 |
| 经营活动产生的现金流量: | | | | |
| 经营活动现金流入小计 | 380,894,133.51 | 259,851,435.62 | 121,875,405.04 | 555,316,341.52 |
| 经营活动现金流出小计 | 300,536,561.3 | 200,591,860.15 | 105,981,620.46 | 378,572,031.86 |
| 经营活动产生的现金流量净额 | 80,357,572.21 | 59,259,575.47 | 15,893,784.58 | 176,744,309.66 |
| 投资活动产生的现金流量: | | | | |
| 投资活动现金流入小计 | 2,636,471,659.37 | 1,788,460,900.89 | 939,892,983.42 | 3,576,424,017.64 |
| 投资活动现金流出小计 | 2,763,364,607.91 | 1,907,538,317.56 | 1,247,626,075.25 | 3,719,916,104.25 |
| 投资活动产生的现金流量净额 | -126,892,948.54 | -119,077,416.67 | -307,733,091.83 | -143,492,086.61 |
| 筹资活动产生的现金流量: | | | | |
| 筹资活动现金流入小计 | - | - | - | - |
| 筹资活动现金流出小计 | 103,690,579.39 | 103,593,980.99 | - | 77,446,629.3 |
| 筹资活动产生的现金流量净额 | -103,690,579.39 | -103,593,980.99 | - | -77,446,629.3 |
| 汇率变动对现金及现金等价物的影响 | -194,786.4 | -116,597.95 | -46,718.16 | -40,814.55 |
| 现金及现金等价物净增加额 | -150,420,742.12 | -163,528,420.14 | -291,886,025.41 | -44,235,220.8 |
| 期末现金及现金等价物余额 | 872,550,869.81 | 859,443,191.79 | 731,085,586.52 | 1,022,971,611.93 |
| 补充资料: | | | | |
| 现金及现金等价物的净增加额 | - | -163,528,420.14 | - | -44,235,220.8 |
最新报告期：2026-10-27| 研究机构 | 分析师 | 预测每股收益(元) | 更新日 |
| 2026年 | 2027年 | 2028年 |
| 中金公司 | 俞波,张琎,冯喜鹏 | 1.66 | 1.72 | -- | 2026-10-27 |
| 中金公司 | 俞波,张琎,冯喜鹏 | 1.74 | 1.79 | -- | 2026-08-27 |
| 中泰证券 | 祝嘉琦,谢木青 | 1.87 | 1.94 | 2.30 | 2026-08-26 |